Want to join the conversation?
$CAG announced restructuring plans to improve profitability, advance its growth agenda and unlock shareholder value. $CAG expects to realize at least $300MM of efficiency benefits within next 3 years through a combination of reductions in SG&A and enhancements to trade spend processes and tools.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.